Recent collaborative work published by Frontiers in Molecular Neuroscience
Frontiers in Molecular Neuroscience have recently published Transpharmation's collaborative research with Cindy Périer, Amy Fisher and Mikhail Kalinichev, exploring the efficacy of BoNT/A for inflammatory Pain in Mice. For over three decades, BoNT/A (botulinum neurotoxin Type A) has been used to treat muscle hyperactivity. Following studies in animals demonstrating inhibition of pain transmitters at peripheral and central levels, BoNTs have also been explored in a growing range of human pain conditions as potential analgesic agents. You can read it here: Frontiers in Molecular Neuroscience. For further information about this study or to enquire about booking in your work with us please contact us.